The CQC expects all healthcare establishments to adhere to changing medication and healthcare guidelines produced by a variety of government agencies.
We offer comprehensive assistance to easily access updates and guidelines that are most relevant to you.
These guidelines may cover devices, drugs and clinical trials, or assessment reports discussing the risks and benefits of newer medications.
You can access our comprehensive library of clinical guidelines below.
Our library of clinical guidelines includes:
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.
NICE guidelines make evidence-based recommendations on a wide range of topics including, preventing and managing specific conditions, improving health and managing medicines.
We highlight relevant NICE guidelines to provide you with easy access to the information that is most important to you.
The Medicines and Healthcare products Regulatory Agency (MHRA) is a government body that produces regular reports on Drug Safety, Drug and Device Alerts, Clinical Trials and Public Assessment Reports.
It aims to make sure you are using the best products and alerts you when research highlights a products is dangerous or less effective than previously thought.
We highlight relevant MHRA news to provide you with easy access to the information that it most important to you.
NHS England release safety alerts or risk of death alerts around products and procedures that could be used in healthcare organisations.
We highlight the most relevant guidance to provide you with the easy access to the information that is most important to you.
Other regulations and standards
To help provide with a broader understanding of all the latest regulations and standards, we highlight any other guidelines that are relevant to the management of medication in a healthcare environment.
This includes guidance from the National Prescribing Centre (NPC), the British National Formulary (BNF), the British Association of Psychopharmacology (BAP), the National Patient Safety Agency (NPSA) and any important information related to the Mental Health Act (MHA).